BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34928321)

  • 1. 18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization.
    Packard RRS; Votaw JR; Cooke CD; Van Train KF; Garcia EV; Maddahi J
    Eur Heart J Cardiovasc Imaging; 2022 Nov; 23(12):1636-1644. PubMed ID: 34928321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved myocardial blood flow estimation with residual activity correction and motion correction in
    Otaki Y; Van Kriekinge SD; Wei CC; Kavanagh P; Singh A; Parekh T; Di Carli M; Maddahi J; Sitek A; Buckley C; Berman DS; Slomka PJ
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1881-1893. PubMed ID: 34967914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic efficiency and incremental value of myocardial blood flow quantification by CZT SPECT for patients with coronary artery disease].
    Pang ZK; Wang J; Chen Y; Chu HX; Zhang MY; Li JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):494-500. PubMed ID: 35589599
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated myocardial flow reserve (iMFR) assessment: optimized PET blood flow quantification for diagnosis of coronary artery disease.
    Poitrasson-Rivière A; Moody JB; Renaud JM; Hagio T; Arida-Moody L; Buckley CJ; Al-Mallah MH; Nallamothu BK; Weinberg RL; Ficaro EP; Murthy VL
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):136-146. PubMed ID: 37807004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative myocardial perfusion
    Freitag MT; Bremerich J; Wild D; Haaf P; Zellweger MJ; Caobelli F
    J Nucl Cardiol; 2022 Apr; 29(2):464-473. PubMed ID: 32676910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of myocardial blood flow using
    Moody JB; Poitrasson-Rivière A; Hagio T; Buckley C; Weinberg RL; Corbett JR; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2021 Oct; 28(5):2313-2329. PubMed ID: 32002847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease.
    Valenta I; Quercioli A; Schindler TH
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):387-96. PubMed ID: 24631507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Absolute Myocardial Blood Flow Quantification on the Diagnostic Performance of PET-Based Perfusion Scans Using
    Rasmussen LD; Gormsen LC; Ejlersen JA; Karim SR; Westra J; Knudsen LL; Kirk J; Søndergaard HM; Mortensen J; Knuuti J; Christiansen EH; Eftekhari A; Bøttcher M; Winther S
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e016138. PubMed ID: 38227687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of quantitative myocardial blood flow assessment by NaI(Tl) SPECT in detecting significant stenosis: a prospective, multi-center study.
    Wang L; Zheng Y; Zhang J; Wang M; Wu D; Wang Y; Qiu H; Hsu B; Fang W
    J Nucl Cardiol; 2023 Apr; 30(2):769-780. PubMed ID: 35971031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Myocardial Perfusion Imaging Diagnostics Improve Detection of Functionally Significant Coronary Artery Stenosis by 13N-ammonia Positron Emission Tomography.
    Lee JM; Kim CH; Koo BK; Hwang D; Park J; Zhang J; Tong Y; Jeon KH; Bang JI; Suh M; Paeng JC; Cheon GJ; Na SH; Ahn JM; Park SJ; Kim HS
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease.
    Pang Z; Wang J; Li S; Chen Y; Wang X; Li J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):367-378. PubMed ID: 32914404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging.
    Danad I; Uusitalo V; Kero T; Saraste A; Raijmakers PG; Lammertsma AA; Heymans MW; Kajander SA; Pietilä M; James S; Sörensen J; Knaapen P; Knuuti J
    J Am Coll Cardiol; 2014 Oct; 64(14):1464-75. PubMed ID: 25277618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Motion Correction for Myocardial Blood Flow Measurements and Diagnostic Performance of
    Kuronuma K; Wei CC; Singh A; Lemley M; Hayes SW; Otaki Y; Hyun MC; Van Kriekinge SD; Kavanagh P; Huang C; Han D; Dey D; Berman DS; Slomka PJ
    J Nucl Med; 2024 Jan; 65(1):139-146. PubMed ID: 38050106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease.
    Stuijfzand WJ; Uusitalo V; Kero T; Danad I; Rijnierse MT; Saraste A; Raijmakers PG; Lammertsma AA; Harms HJ; Heymans MW; Huisman MC; Marques KM; Kajander SA; Pietilä M; Sörensen J; van Royen N; Knuuti J; Knaapen P
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
    Maddahi J; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Dorbala S; Garcia EV; Feldman J; Heller GV; Knuuti JM; Martinez-Clark P; Pelletier-Galarneau M; Shepple B; Tamaki N; Tranquart F; Udelson JE
    J Am Coll Cardiol; 2023 Oct; 82(16):1598-1610. PubMed ID: 37821170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute flow or myocardial flow reserve for the detection of significant coronary artery disease?
    Joutsiniemi E; Saraste A; Pietilä M; Mäki M; Kajander S; Ukkonen H; Airaksinen J; Knuuti J
    Eur Heart J Cardiovasc Imaging; 2014 Jun; 15(6):659-65. PubMed ID: 24408930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated pixel-wise quantitative CMR-myocardial perfusion with CMR-coronary angiography to detect hemodynamically significant coronary artery disease.
    Zhao SH; Guo WF; Yao ZF; Yang S; Yun H; Chen YY; Han TT; Zhou XY; Fu CX; Zeng MS; Li CG; Pan CZ; Jin H
    Eur Radiol; 2023 Oct; 33(10):7238-7249. PubMed ID: 37145148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of quantitative absolute myocardial blood flow estimates from dynamic CZT-SPECT improves the detection of coronary artery disease.
    Liu FS; Wang SY; Shiau YC; Wu YW
    J Nucl Cardiol; 2022 Oct; 29(5):2311-2321. PubMed ID: 34240342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of myocardial blood flow and myocardial flow reserve with 99mTc-sestamibi dynamic SPECT/CT to enhance detection of coronary artery disease.
    Hsu B; Chen FC; Wu TC; Huang WS; Hou PN; Chen CC; Hung GU
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2294-306. PubMed ID: 25143072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.
    Maddahi J; Lazewatsky J; Udelson JE; Berman DS; Beanlands RSB; Heller GV; Bateman TM; Knuuti J; Orlandi C
    J Am Coll Cardiol; 2020 Jul; 76(4):391-401. PubMed ID: 32703509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.